nalmefene intranasal (Pending FDA Approval)

Brand and Other Names:
  • Print
Sections

Dosing & Uses

Opioid Overdose

Pending FDA approval for treatment of opioid overdose

Next:

Pharmacology

Mechanism of Action

An opioid antagonist, is a 6-methylene analogue of naltrexone, prevents or reverses effects of opioids, including respiratory depression, sedation, and hypotension

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.